---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

In a press release out on November 23, Travelzoo Announces CEO Succession in Summer 2010

Chris Loughlin to Become Chief Executive Officer and Holger Bartel to Become Chairman of the Board of Directors on July 1, 2010

NEW YORK, Nov 23, 2009 -- Travelzoo Inc. (NASDAQ:TZOO), a global Internet media company, today announced that Christopher "Chris" Loughlin, executive vice president, Europe, will become the company's chief executive officer, effective July 1, 2010, while CEO Holger Bartel will become chairman of the board of directors.

About Travelzoo

Travelzoo Inc. is a global Internet media company. With more than 18 million subscribers in North America, Europe, and Asia Pacific and 20 offices worldwide, Travelzoo(R) publishes deals from more than 2,000 travel and entertainment companies. Travelzoo's deal experts review offers to find the best deals and confirm their true value. In Asia Pacific, Travelzoo is independently owned and operated by Travelzoo (Asia) Ltd. and Travelzoo Japan K.K. under a license agreement with Travelzoo Inc.

NexMed, Inc. (Nasdaq: NEXM) trading at $0.187 per share on trading volume of 3.76M shares.

In a press release out on November 23, NexMed, Inc. to Acquire Bio-Quant, Inc.

Cash Flow Positive, Growing Business Provides NexMed with Pre-clinical Capabilities, Added Licensing Expertise and Critical Mass;

EAST WINDSOR, N.J., Nov 23, 2009 -- --Transaction May Enable Continued NASDAQ Listing --Conference Call to Be Held at 9:00 am EST Today NexMed, Inc. (Nasdaq: NEXM), a developer of products based on the NexACT(R) technology, today announced that it has entered into a definitive agreement to acquire Bio-Quant, Inc., a revenue generating privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA. Upon closing of the transaction, which is expected before the end of the year, Bio-Quant will become a wholly-owned subsidiary of NexMed. Bassam Damaj, Ph.D., co-founder, current Chief Executive Officer and Chief Scientific Officer of Bio-Quant, will become Chief Executive Officer of NexMed, replacing Vivian Liu, who will transition to the role of Executive Vice President and, in that capacity, Ms. Liu will continue to be responsible for leading the business development and licensing efforts for NexMed's clinical programs. Mark Westgate will remain as NexMed's Chief Financial Officer. The Board will be composed of three Bio-Quant nominees and four NexMed nominees, and Ms. Liu is expected to be appointed as Chairman of the Board.

About NexMed

NexMed's pipeline includes a late stage terbinafine treatment for onychomycosis, a late stage alprostadil treatment for erectile dysfunction, a Phase 2 alprostadil treatment for female sexual arousal disorder, and an early stage treatment for psoriasis. For further information, go to www.nexmed.com.

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) trading at $2.19 on a volume of 710,627 shares

In a press release out on November 23, ARIAD to Present Data on Pan-BCR-ABL Inhibitor AP24534 at 51st American Society of Hematology Meeting

Clinical Proof-of-Concept Data to be Presented December 7, 2009

CAMBRIDGE, Mass., Nov 23, 2009 -- --ARIAD to Hold Conference Call to Discuss Findings December 8, 2009 ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD's investigational, multi-targeted kinase inhibitor and pan-BCR-ABL inhibitor, AP24534, at the 51st Annual Meeting of the American Society of Hematology (ASH) being held in New Orleans, Louisiana, December 5-8, 2009. The Phase 1 clinical proof-of-concept data on AP24534 in patients with resistant and refractory chronic myeloid leukemia (CML) will be presented by Jorge Cortes, M.D., Professor and Deputy Chair, Department of Leukemia at the M.D. Anderson Cancer Center.

About ARIAD

ARIAD's vision is to transform the lives of cancer patients with breakthrough medicines. The Company's mission is to discover, develop and commercialize small-molecule drugs to treat cancer in patients with the greatest and most urgent unmet medical need -- aggressive cancers where current therapies are inadequate. ARIAD's lead product candidate, ridaforolimus, is an investigational mTOR inhibitor in Phase 3 clinical development in patients with advanced sarcomas and is being developed in collaboration with Merck & Co., Inc. ARIAD's second product candidate, AP24534, is an investigational multi-targeted kinase inhibitor in Phase 1 clinical development in patients with hematological cancers. ARIAD has an exclusive license to pioneering technology and patents related to certain NF-kB cell-signaling activity, which may be useful in treating certain diseases. For additional information about the Company, please visithttp://www.ariad.com.

Energy XXI Limited (Nasdaq:EXXI) trading at $2.12 on a volume of 957,927 shares

In a press release out on November 23, Energy XXI to Increase Interests in Core Operated Gulf of Mexico Oil Properties

HOUSTON, Nov 23, 2009 -- Energy XXI (Bermuda) Limited (Nasdaq:EXXI) (LSE:EXXI) today announced it has executed a conditional purchase/sale agreement to acquire certain Gulf of Mexico shelf oil and natural gas interests from MitEnergy Upstream LLC, a subsidiary of Mitsui & Co., Ltd. (head-office: Tokyo, Japan) (Nasdaq:MITSY) (Tokyo Stock Exchange Symbol: (TSE:8031)), for a headline cash consideration of $283 million.

About the Company

Energy XXI is an independent oil and natural gas exploration and production company whose growth strategy emphasizes acquisitions, enhanced by its value-added organic drilling program. The company's properties are located in the U.S. Gulf of Mexico waters and the Gulf Coast onshore. Collins Stewart Europe Limited and Macquarie Capital (Europe) Limited are Energy XXI listing brokers in the United Kingdom. To learn more, visit the Energy XXI website at www.energyXXI.com.

Xtremepicks.com profiles early stage microcap and growth stocks that provide innovative products or services resulting in potentially "hyper-growth" opportunities. Often, these companies have yet to be recognized by Wall Street and the undiscovered nature of Xtremepicks.com's profile companies provide our members the opportunity to learn about these companies at their development stage, and more importantly before they possibly "turn the corner" and get exposed to a much larger investing audience.

Xtremepicks.com (www.Xtremepicks.com) has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by Xtremepicks.com to be accurate, and should not be considered to be all-inclusive. Xtremepicks.com is a leading information resource for evaluating investment opportunities in small and microcap stocks. We focus on a limited number of companies in order to provide comprehensive coverage, including unique investment related features not available anywhere else on the Internet. To feature a company or to get more information, please visit us at www.Xtremepicks.com or email us at info@Xtremepicks.com Xtremepicks.coms affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Xtremepicks.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

To view full disclaimers, go to http://www.Xtremepicks.com/disclaimer.htm

CONTACT: Xtremepicks.com e-mail: Info@xtremepicks.com WWW: http://www.Xtremepicks.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Chairman and Travelzoo founder Ralph Bartel, who has served as the chairman of the board of directors for more than eleven years, will continue to serve as one of the five members of Travelzoo's board of directors.

Holger Bartel, chief executive officer and member of the board of directors, stated: "We have great confidence that Chris will be able to continue to grow Travelzoo as a global brand and as the world's most trusted publisher of travel deals. Throughout his career at Travelzoo, Chris has shown his dedication to the business and its employees and his range of experience in both North America and Europe will be invaluable in taking up the post of CEO in July 2010."

Speaking of his appointment, Loughlin said, "I am delighted to accept this position as CEO of Travelzoo. I am looking forward to working with Holger to ensure a smooth transition in the run up to July 1, 2010 and I am committed to carrying on the exemplary standard he has set, not just in this company but in the Internet media industry and the travel industry as a whole."

Loughlin, 36, joined Travelzoo in 2001 as vice president of business development based in the company's Silicon Valley office in Mountain View, California. In 2003, he moved to Chicago to expand Travelzoo's operations in North America. Loughlin moved to London in 2005 to take up the post of executive vice president, Europe, where he launched Travelzoo in the U.K. and subsequently in Germany, France and Spain. Loughlin holds a BSc(Hons) in Technology Management from Staffordshire University and an MBA from Columbia University Graduate School of Business in New York City. He is married with two children. In May 2009, Loughlin was named the "2009 Young Entrepreneur of the Year" by The British Travel & Hospitality Industry Hall of Fame.

Loughlin, who is currently based in the company's London office, will transfer to the company's global headquarters on Madison Avenue in New York.

About Travelzoo

Travelzoo Inc. is a global Internet media company. With more than 18 million subscribers in North America, Europe, and Asia Pacific and 20 offices worldwide, Travelzoo(R) publishes deals from more than 2,000 travel and entertainment companies. Travelzoo's deal experts review offers to find the best deals and confirm their true value. In Asia Pacific, Travelzoo is independently owned and operated by Travelzoo (Asia) Ltd. and Travelzoo Japan K.K. under a license agreement with Travelzoo Inc.

Certain statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. These forward-looking statements may include, but are not limited to, statements about our plans, objectives, expectations, prospects and intentions, markets in which we participate and other statements contained in this press release that are not historical facts. When used in this press release, the words "expect", "predict", "project", "anticipate", "believe", "estimate", "intend", "plan", "seek" and similar expressions are generally intended to identify forward-looking statements. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including changes in our plans, objectives, expectations, prospects and intentions and other factors discussed in our filings with the SEC. We cannot guarantee any future levels of activity, performance or achievements. Travelzoo undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release. Travelzoo and Top 20 are registered trademarks of Travelzoo. All other names are trademarks and/or registered trademarks of their respective owners.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6106061&lang=en

SOURCE: Travelzoo

Travelzoo 
Mindy Joyce, +1-212-484-4918 (North America) 
mjoyce@travelzoo.com 
Louise Hodges, +44 20 7203 2026 (Europe) 
lhodges@travelzoo.com

The Travelzoo Network in the UK now reaches an average of 50 million page views per month. The UK launch follows a successful rollout in the US, where the Network reaches over 500 million page impressions per month across 150 leading US websites.

"Partnerships with these important organisations and companies are a testament to the quality of Travelzoo's content. We only publish relevant travel and entertainment deals that are authentic, checked and truly available. Our partners value our commitment to quality deals - that is why they want to be part of this network," said Melanie Bower, Vice President, Travelzoo Network, Europe.

Justin Reid, Head of Online and CRM at Visit Britain said, "Being part of the Travelzoo Network in the UK gives Visit Britain additional content that our users can use. We particularly like the fact that Travelzoo has access to a wide range of offers from many different travel & entertainment companies and that they quality check the deals before publishing them on our site."

Travelzoo deals are displayed on partners' websites based on user origin and destination search criteria or the theme of the partner's website. This gives users relevant content when searching for travel and entertainment information. For example, recently on AOL Travel's UK Holidays page, the Travelzoo Network showcased an GBP80 per person stay at the luxurious Fairmont, St. Andrews, including spa treatments.

Travel companies with deals published in the Travelzoo Network include Accor Hotels, Ambassador Tickets, Billy Chicago, bmibaby, The Co-operative Group, Destinology, DFDS Seaways, Economy Car Hire, Expedia.co.uk, Flight Centre, Hilton International, The Holiday Place, Iglu.com, KLM Air France, lastminute.com, Lufthansa, Monarch Airlines, Morgans Hotel Group, Netflights, Marriott UK & Ireland, Mark's Travel, Opodo, Qwerty Travel, STA Travel, Starwood Hotels & Resorts, and Sol Melia Hotels & Resorts, The Walt Disney Company, Zorro West End.

About Travelzoo Travelzoo is a global Internet media company. Travelzoo's media properties, which reach more than 18 million travel enthusiasts in the US, Australia, Canada, China, France, Germany, Hong Kong, Japan, Spain, Taiwan and the UK, include the Travelzoo(R) website (http://www.travelzoo.com), the Top 20(R) list, the Newsflash(TM) email alert service, the Travelzoo Network(TM), the SuperSearch(TM) search tool, and the Fly.com(TM) search engine. Travelzoo publishes offers from more than 1,000 advertisers from around the world. Travelzoo's deal experts review offers to find the best travel deals and confirm their true value. Travelzoo's global headquarters is in New York City.

About Travelzoo in Europe

Travelzoo has operated in Europe since 2005. Travelzoo's European media properties, which reach more than 3 million travel enthusiasts in France, Germany, Spain and the UK, through its newsletters, include the Travelzoo Top 20(R) list, the Newsflash(TM) email alert service, and the Travelzoo(R) websites (http://www.travelzoo.fr, http://www.travelzoo.de, http://www.travelzoo.es, http://www.travelzoo.co.uk). Travelzoo also operates the Travelzoo Network(TM), the SuperSearch(TM) search tool, and the Fly.com(TM) search engine in the UK.

Certain statements contained in this press release that are not historical facts may be forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. These forward looking statements may include, but are not limited to, statements about our plans, objectives, expectations, prospects and intentions, markets in which we participate and other statements contained in this press release that are not historical facts. When used in this press release, the words "expect", "predict", "project", "anticipate", "believe", "estimate", "intend", "plan", "seek" and similar expressions are generally intended to identify forward looking statements. Because these forward looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward looking statements, including changes in our plans, objectives, expectations, prospects and intentions and other factors discussed in our filings with the SEC. We cannot guarantee any future levels of activity, performance or achievements. Travelzoo undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release. Travelzoo and Top 20 are registered trademarks of Travelzoo. All other company and product names mentioned are trademarks of their respective owners.

Travelzoo (Europe) Ltd
    90 Long Acre
    London
    WC2E 9RZ
    United Kingdom

    Media Contact:

    Glyn Owen
    +44(0)20-7203-2015
    gowen@travelzoo.com

Media Contact: Glyn Owen, +44(0)20-7203-2015, gowen@travelzoo.com